We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biofluid Ribonucleic Acid Isolation Kit Launched

By LabMedica International staff writers
Posted on 20 Dec 2012
An isolation kit for the extraction of small ribonucleic acid (RNA) from serum, plasma, urine and other biofluids has been specifically optimized for such applications.

The new biofluids kit allows scientists to obtain high quality microRNA from virtually all types of biofluids in just 45 minutes and the workflow is completed in six simple steps without the use of hazardous chemicals such as phenol and chloroform.

The miRCURY RNA Isolation Kit – Biofluids (Exiqon; Vedbaek, Denmark) is optimized to work with company's highly sensitive miRCURY LNA Universal real-time microRNA polymerase chain reaction (qPCR) platform. More...
The Isolation Kit is ideal for use with urine samples together with Exiqon’s Toxicology Focus microRNA PCR Panels, and for serum and plasma samples with the Serum/Plasma Focus microRNA PCR Panels, or indeed any of the almost 2,000 prevalidated qPCR microRNA assays available. The Isolation Kit – Biofluids can be used with a centrifuge or a vacuum manifold is provided in pack sizes of 10 and 50 units.

The company offers a complete range of PCR products for microRNA analysis, which includes ready-to-use panels for genome-wide screening of human, mouse and rat microRNAs, numerous focus panels, the fully flexible Pick & Mix panels, spike-in kits, cDNA synthesis and PCR Master Mix kits, as well as unique qPCR data analysis software. Customers that have identified novel microRNAs can take advantage of Exiqon’s proprietary LNA chemistry and unique design algorithm through easy-to-use online tool for high quality design of custom microRNA qPCR assays.

Henrik M. Pfundheller, Senior Vice President Sales and Marketing at Exiqon, said, "Our customers want fully integrated systems that allow highly robust and sensitive microRNA profiling in difficult samples such as blood and urine, and we deliver the solution with this new kit. We have not only optimized the protocols to ensure the highest yield in the market but have also made sure that the sample does not contain any inhibitors which may jeopardize the downstream PCR analysis."

Related Links:

Exiqon




New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.